Case Based Panel Discussion - 2019 ALK Positive, Progression after Success on ALK Inhibitor

dbrock's picture
Progression after success on an ALK inhibitor - do you continue the ALK inhibitor when transitioning to a chemo based treatment?
H. Jack West, MD, Founder, President and CEO
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Jonathan Riess and Suki Padda.

Jonathan W. Riess, MD MS is Associate Professor of Medicine in the Division of Hematology/Oncology at UC Davis Comprehensive Cancer Center. Sukhmani Padda MD is Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center.  In this video series, the doctors discuss a series of cases related to a diagnosis of ALK Positive NSCLC. This next panel discussion is regarding progression after success on an ALK inhibitor. Do you continue the ALK inhibitor when transitioning to a chemo based treatment?

 

Video Language: 

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation